Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Interventional
×
abelacimab
×
Clear all
Filters
3
NCT05171049
2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3
Terminated
1,150 enrolled
NCT05171075
2025-12-19
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3
Active not recruiting
417 enrolled